Glycation--a sweet tempter for neuronal death - PubMed (original) (raw)
Review
Glycation--a sweet tempter for neuronal death
Seiji Kikuchi et al. Brain Res Brain Res Rev. 2003 Mar.
Abstract
Glycation, one of the post-translational modifications of proteins, is a nonenzymatic reaction initiated by the primary addition of a sugar aldehyde or ketone to the amino groups of proteins. In the early stage of glycation, the synthesis of intermediates leading to the formation of Amadori compounds occurs. In the late stage, advanced glycation end products (AGE) are irreversibly formed after a complex cascade of reactions. Several AGEs have been characterized chemically, while other new compounds remain to be identified. To date, studies of the contribution of glycation to diseases have been primarily focused on its relationship to diabetes and diabetes-related complications. However, glucose-induced damage is not limited to diabetic patients. Although it does not cause rapid or remarkable cell damage, glycation advances slowly and accompanies every fundamental process of cellular metabolism. It has recently become clear that glycation also affects physiological aging and neurodegenerative diseases such as Alzheimer's disease and amyotrophic lateral sclerosis. Glycation alters the biological activity of proteins and their degradation processes. Protein cross-linking by AGE results in the formation of detergent-insoluble and protease-resistant aggregates. Such aggregates may interfere with both axonal transport and intracellular protein traffic in neurons. In addition, glycation reactions lead to the production of reactive oxygen species. Conversely, glycation is promoted by oxidative stress. We speculate on the presence of synergism between glycation and oxidative stress. In this review, we provide an outline of glycation and propose some possible mechanisms of its cytotoxicity and defense systems against it.
Similar articles
- The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.
Saeed M, Kausar MA, Singh R, Siddiqui AJ, Akhter A. Saeed M, et al. Curr Protein Pept Sci. 2020;21(9):846-859. doi: 10.2174/1389203721666200505101734. Curr Protein Pept Sci. 2020. PMID: 32368974 Review. - Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease.
Takeuchi M, Kikuchi S, Sasaki N, Suzuki T, Watai T, Iwaki M, Bucala R, Yamagishi S. Takeuchi M, et al. Curr Alzheimer Res. 2004 Feb;1(1):39-46. doi: 10.2174/1567205043480582. Curr Alzheimer Res. 2004. PMID: 15975084 Review. - In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways.
Booth AA, Khalifah RG, Todd P, Hudson BG. Booth AA, et al. J Biol Chem. 1997 Feb 28;272(9):5430-7. doi: 10.1074/jbc.272.9.5430. J Biol Chem. 1997. PMID: 9038143 - Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury.
Zhang H, Wang Y, Yan S, Du F, Wu L, Yan S, Yan SS. Zhang H, et al. Cell Death Dis. 2014 Jun 12;5(6):e1288. doi: 10.1038/cddis.2014.248. Cell Death Dis. 2014. PMID: 24922072 Free PMC article.
Cited by
- Effect of the age cross-link breaker alagebrium on anterior segment physiology, morphology, and ocular age and rage.
Kiland JA, Gabelt BT, Tezel G, Lütjen-Drecoll E, Kaufman PL. Kiland JA, et al. Trans Am Ophthalmol Soc. 2009 Dec;107:146-58. Trans Am Ophthalmol Soc. 2009. PMID: 20126491 Free PMC article. - Effect of non-enzymatic glycation on cystatin: a spectroscopic study.
Bhat SA, Sohail A, Siddiqui AA, Bano B. Bhat SA, et al. J Fluoresc. 2014 Jul;24(4):1107-17. doi: 10.1007/s10895-014-1391-2. Epub 2014 May 2. J Fluoresc. 2014. PMID: 24789772 - Nutrition and the risk of Alzheimer's disease.
Hu N, Yu JT, Tan L, Wang YL, Sun L, Tan L. Hu N, et al. Biomed Res Int. 2013;2013:524820. doi: 10.1155/2013/524820. Epub 2013 Jun 20. Biomed Res Int. 2013. PMID: 23865055 Free PMC article. Review. - The 2022 Lady Estelle Wolfson lectureship on neurofilaments.
Petzold A. Petzold A. J Neurochem. 2022 Nov;163(3):179-219. doi: 10.1111/jnc.15682. Epub 2022 Sep 19. J Neurochem. 2022. PMID: 35950263 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical